Share this post on:

Product Name :
Varenicline Tartrate

Search keywords :
Nicotinic Acetylcholine Receptor alpha 4

drugId :
null

Target Vo:
Nicotinic acetylcholine receptor alpha-4/beta-2

Target Vo Short Name :
Nicotinic acetylcholine receptor alpha-4/beta-2

Moa_Name:
Nicotinic acetylcholine receptor alpha-4/beta-2 agonists

First Approval Country :
United States

First Approval Date Filter:
2006

Origin Company_Name :
Pfizer Pharmaceuticals Ltd

Active Company_Name :
Heinrich Mack Nachf. Gmbh & Co Kg

Active Indication_Name:
Xerophthalmia

In Active Indication_Name:
Machado-Joseph Disease

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glucocorticoid Receptor alpha Antibody
ATF4 Antibody
SUMO1 Antibody (YA047): SUMO1 Antibody (YA047) is a non-conjugated and Rabbit origined monoclonal antibody, targeting to SUMO1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Betaine hydrochloride